Campbell/Spillane Substance Use Research - Interview with George Uhl

Abstract

George R. Uhl, MD, PhD, is Professor of Neurology and Professor of Pharmacology at the University of Maryland School of Medicine. He is also affiliated with the New Mexico Veterans Affairs Health Care System-Raymond G. Murphy Medical Center. He received his medical degree and PhD from Johns Hopkins University School of Medicine and has been in practice for more than 20 years. He was Branch Chief and Acting Scientific Director for the NIH’s National Institute on Drug Abuse. Dr. Uhl is board certified in neurology with a PhD in neuropharmacology and with substantial contributions to clinical trials, human genetics, mouse genetics, neuropharmacology and in vitro studies. He now manages a research program based at the New Mexico VA Healthcare System and his own laboratory and translational/clinical research. He has long studied the mu opiate receptor, at which several RLS drugs work, and the RLS gene PTPRD, for which he has discovered novel ligands. Dr Uhl also has experience in addiction and Parkinson’s disease. His major research interests include: Translational studies of complex genetics of RLS and other brain disorders; Mechanisms of RLS, addictions and Parkinson’s disease, and; Discovery of novel therapeutic approaches to RLS, addictions and Parkinson’s disease. At the Foundation, Dr. Uhl is a member of the Research Grant and Brain Bank committees. Sources: https://www.medschool.umaryland.edu/profiles/Uhl-George/ Accessed 17 Mar 2023. https://health.usnews.com/doctors/george-uhl-612657 Accessed 17 Mar 2023. https://www.rls.org/about-us/board#uhl Accessed 17 Mar 2023.